COPD
News from the FDA/CDC
FDA warns AstraZeneca over ‘misleading claims’ about COPD drug
The FDA issued the warning letter on Aug. 4 and published it on Aug. 15.
Latest News
Generic inhalers for COPD support hold their own
“I don’t see a clinical reason why one would ever need to get the brand name over the generic version.”
From the Journals
COPD plus PRISm may promote frailty progression
Frailty progression was significantly accelerated in patients with PRISm and COPD.
From the Journals
Classification of COPD exacerbation predicts prognosis
Patients hospitalized with severe exacerbations of ECOPD are at increased risk for worse clinical outcomes and death.
From the Journals
COPD: Large-scale study suggests protective role for vitamin D
“Our findings imply that vitamin D might play a role in progression of COPD.”
Latest News
LAMA-LABA surpasses corticosteroid combination as COPD therapy
Large matched cohort study suggests stronger safety and effectiveness outcomes with LAMA-LABA inhalers vs. ICS-LABA inhalers.
Feature
Parsing the split-decision victory for biologics in COPD
It’s tough to keep up with the proliferation of monoclonal antibodies.
From the Journals
Electronic nose may sniff out early lung cancer in COPD
Molecular profiling of exhaled breath using electronic nose (eNose) technology has shown potential as a method of early detection by identifying...
Perspectives
Antibiotics for acute exacerbation of COPD: It’s still controversial
Who gets an antibiotic and who doesn’t for AECOPD treatment is controversial.
Feature
The breathtaking effects of climate change
“What we’re going to see is not just new diseases but also exacerbation of chronic diseases.”